Friedmann Nadav

Avg. Two Year Performance

6% Avg. Purchase Return
3% Compound
6% Avg. Sale Return
3% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(2%)(21%)(3%)(53%)6%
Purchase Success Rate0 of 10 of 10 of 10 of 11 of 1
Average Sale Return7%13%11%(17%)6%
Sale Success Rate9 of 138 of 139 of 133 of 136 of 13

Pain Therapeutics Inc.

Drugs » Drug Manufacturers - Other

Chief Medical Officer, Director:

Holdings: 80.05K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--